Caso contributivo
Quando il disturbo del neurosviluppo ha un substrato genetico: un caso di sindrome di Kleefstra
When the neurodevelopmental disorder has a genetic cause: Kleefstra syndrome
Lorena Sorasio1, Luisa Franceschi2, Lisa Pavinato3, Antonella Peduto1
1SC di Pediatria, ASO S. Croce e Carle, Cuneo
2Scuola di Specializzazione in Pediatria, Università di Torino
3Dipartimento di Scienze Mediche, Università di Torino
Aprile 2021 | DOI: 10.53126/MEBXXIV114
Abstract
Neurodevelopmental disorders (ND) have an important prevalence in children; intellectual disability in particular occurs in a heterogeneous group of genetic conditions. The evolution of molecular cytogenetic techniques and the recent advances in exome sequencing technologies have enormously implemented the possibilities of diagnostic classification in children with cognitive disabilities due to genetics. The paper presents the case of a patient with a neurodevelopmental disorder who was diagnosed with Kleefstra (KS) syndrome, caused by a point mutation de novo of EHMT1 gene.
Riassunto
I disturbi del neurosviluppo (ND) hanno una prevalenza rilevante in età pediatrica; la disabilità intellettiva in particolare ricorre in un gruppo eterogeneo di condizioni genetiche. L’evoluzione delle tecniche di citogenetica molecolare e i recenti progressi nelle tecnologie di sequenziamento dell’esoma hanno enormemente implementato le possibilità di inquadramento diagnostico nei bambini con disabilità cognitiva a causa genetica. Presentiamo il caso di un bambino con ND in cui è stata diagnosticata la sindrome di Kleefstra, causata da una mutazione puntiforme de novo del gene EHMT1.
Contenuto riservato
Per leggere l'articolo è necessario effettuare il login.
Per l'acquisto del singolo articolo scrivi a
abbonamenti@medicoebambino.com
(la mail si prepara da sola con gli estremi dell'articolo);
se accedi, la richiesta parte con un click.
Classificazione MeSH
Bibliografia
- De Rubeis S, Xin H, Goldberg AP, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014;515(7526):209-15. DOI: 10.1038/nature13772.
- Satterstrom FK, Kosmicki JA, Wang J, et al. Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. Cell 2020;180(3):568-84. doi: 10.1016/j.cell.2019.12.036.
- Leonard H, Wen X. The epidemiology of mental retardation: challenges and opportunities in the new millenium. Ment Retard Dev Disabil Res Rev 2002;8(3):117-34. doi: 10.1002/mrdd.10031.
- Moeschhler JB, Shevell M. Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics 2014;134(3):e903-18. DOI: 10.1542/peds.2014-1839.
- Grayton HM, Fernandes C, Rujescu D, Collier DA. Copy number variations in neurodevelopmental disorders. Prog Neurobiol 2012;99(1):81-91. DOI: 10.1016/j.pneurobio.2012.07.005.
- Kharbanda M, Tolmie J, Joss S. How to use… microarray comparative genomic hybridization to investigate developmental disorders. Arch Dis Child Educ Pract Ed 2015;100(1):24-9. doi: 10.1136/archdischild-2014-306022.
- Riggs ER, Wain KE, Riethmaier D, et al. Chromosomal microarray impacts clinical management. Clin Genet 2014;85(2):147-53. doi: 10.1111/cge.12107.
- Miller DT, Adam MP, Aradhya S, et al. Consensus Statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86(5):749-64. doi: 10.1016/j.ajhg.2010.04.006.
- Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of Mendelian disorders. N Engl J Med 2013; 369:1502-1511. DOI: 10.1056/NEJMoa1306555.
- Deciphering Developmental Disorders Study. Large-scale discovery of novel genetic causes of developmental disorders. Nature 2015;519(7542):223-8. doi: 10.1038/nature14135.
- Chérot E, Keren B, Dubourg C, et al. Using medical exome sequencing to identify the causes of neurodevelopmental disorders: Experience of 2 clinical units and 216 patients. Clin Genet 2018;93(3):567-76. doi: 10.1111/cge.13102.
- Willemsen MH, Vultovan Silfhout AT, Nillesen WM, et al. Update on Kleefstra syndrome. Mol Syndromol 2012;2(3-5):202-12. doi: 10.1159/000335648.
- Kleefstra T, de Leeuw N. Kleefstra syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, et al. (eds). GeneReviews® [Internet]. Seattle (WA): University of Washington, 1993.
- Ciaccio C, Scuvera G, Tucci A, et al. New insights into Kleefstra syndrome: report of two novel cases with previously unreported features and literature review. Cytogenet Genome Res 2018;156(3):127-33. doi: 10.1159/000494532.
- Yatsenko SA, Cheung SW, Scott DA, et al. Deletion 9q34.3 syndrome: genotype-phenotype correlations and an extended deletion in a patient with features of Opitz C trigonocephaly. J Med Genet 2005;42(4):328-35. doi: 10.1136/jmg.2004.028258.
- Frega M, Selten M, Mossink B, et al. Distinct pathogenic genes causing intellectual disability and autism exhibit a common neuronal network hyperactivity phenotype. Cell Rep 2020;30(1):173-86.e6. doi: 10.1016/j.celrep.2019.12.002.
- Okayasu T, Quesnel AM, Reinshagen KL, Nadol JB. Otopathology in Kleefstra syndrome: a case report. Laryngoscope 2020;130(8):2028-33. doi: 10.1002/lary.28380.
- Kleefstra T, van Zelst-Stams WA, Nillesen WM, et al. Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. J Med Genet 2009;46(9):598-606. doi: 10.1136/jmg.2008.062950.